Dynamically cross-linked hyaluronic acid hydrogel

By introducing hydrophobic group grafted hyaluronic acid and crosslinked group modified cyclodextrin into the hydrogel, a dynamic crosslinked hydrogel is formed, which solves the complex cell recovery and dynamic performance of the hydrogel culture system. The problem of good and high cost achieves the promotion of cell proliferation and differentiation, as well as the efficient recovery and biofriendliness of cell clusters.

CN115558126BActive Publication Date: 2024-11-15HAINUO BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111615790.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2021-11-29
Filing Date
2021-12-27
Publication Date
2024-11-15
Estimated Expiration
2041-12-27

AI Technical Summary

Technical Problem

The existing hydrogel culture system has problems such as complex cell recovery methods, poor dynamic performance, uneven cell growth and high cost in in vitro cell three-dimensional culture, making it difficult to be suitable for large-scale applications.

Method used

Hyaluronic acid grafted with hydrophobic groups and cyclodextrin modified with crosslinking groups are mixed in aqueous solution to form a dynamic crosslinking hydrogel by initiating a crosslinking reaction, which has good viscoelasticity, self-healing and biological phase. Capacity can regulate cellular behavior and promote the formation of cell clusters.

Benefits of technology

Dynamic cross-linked hydrogels that achieve rapid gel formation, self-healing and degradation are suitable for long-term in vitro culture of various cells, promote cell proliferation and differentiation, reduce the recovery time and cost of cell clusters, and increase cell clusters cluster activity and biofriendliness.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115558126B_ABST
    Figure CN115558126B_ABST
Patent Text Reader

Abstract

The present invention relates to a dynamic cross-linked hyaluronic acid hydrogel, the raw materials of which are a hydrogel prepolymer mixed with a hydrophobic group-modified hyaluronic acid and a cross-linked group-modified cyclodextrin, and a degradable hydrogel is formed by chemical or photo-cross-linking reaction, wherein the modified hyaluronic acid is grafted on the hyaluronic acid with a hydrophobic group that can produce a host-guest interaction with cyclodextrin. The hydrophobic group is selected from butylbenzene, terpenoid or sterol molecules; the cross-linked group of the cyclodextrin is preferably a photocurable group. The present invention also relates to the preparation of the dynamic cross-linked hyaluronic acid hydrogel and its application in three-dimensional cell culture and therapeutic agents. The hydrogel of the present invention has good dynamic mechanical properties, thereby achieving better in vitro regulation of cell behavior, and has a positive promoting effect on the culture of embryonic stem cells, neural stem cells, immune stem cells, the in vitro proliferation of various cancer cells, and the formation of clusters with cancer stem cell characteristics.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of tissue engineering technology, and more specifically to a degradable in vitro 3D cell culture hydrogel material, a preparation method and application thereof. Background Art

[0002] The behavior, function and fate of cells in the human body are closely related to the influence of biochemical and biophysical signals in their microenvironment. The cell microenvironment is composed of the extracellular matrix (ECM), bioactive factors and adjacent cells. In the in vitro 3D culture of cells, the reconstruction of the cell microenvironment and the directional regulation of cell fate are of great significance for studying the determinants of cell fate and using cells to treat diseases. ECM has dynamic mechanical properties. Cells interact with ECM to respond to biophysical signals and then reshape the surrounding environment. Metals, ceramics and synthetic polymers can effectively replace the mechanical functions of tissues (such as teeth, hips, knees, etc.), but there are still great limitations in simulating the dynamic mechanical properties of ECM. Hydrogel materials have dynamic mechanical properties similar to ECM, and more and more hydrogel materials are used in the study of inducing cell behavior. Host-guest self-assembled hydrogels use host-guest self-assembly interactions as crosslinking methods and have highly dynamic mechanical properties. They are a very promising class of hydrogel materials that simulate the dynamic mechanical properties of ECM.

[0003] Hydrogels are increasingly being used to load / deliver stem cells and primary cells to promote tissue regeneration. Using biophysical signals such as hydrogel viscoelasticity, mechanical strength, and degradation properties to regulate cell proliferation, morphology, differentiation, and phenotype matrix deposition plays an extremely important role in guiding 3D cell culture in vitro and cell transplantation in vivo. TM Hydrogels based on Alginate have good biocompatibility and viscoelasticity. Viscoelasticity, as a dynamic mechanical property, plays an important role in affecting the behavior of loaded cells. However, the uncontrollability of stoichiometry limits the application of natural polymers in cell behavior research. Semi-synthetic natural polymers are modified on the basis of natural polymer materials, and chemical structures with known properties are introduced into natural polymer materials to achieve precise regulation of the properties of natural polymer materials, which is of great significance for in-depth research on the influencing factors of regulating cell behavior.

[0004] Since cell clusters are widely used in in vitro models for drug screening, basic research on disease progression and developmental biology, and clinical research on autologous or allogeneic organ cultivation and tissue regeneration, etc., the use of hydrogels for proliferation and culture of cell clusters, cytological research, cell release and collection, and as tissue engineering scaffolds for loading cells for tissue regeneration has great biomedical significance and application prospects.

[0005] In recent years, scientists have discovered that there are cancer cells in tumors that are very similar to embryonic stem cells, and therefore named them cancer stem cells. Although scientists have made some progress in cancer therapy research, the 5-year survival rate of patients with advanced cancer is still very low. One of the reasons is that the cancer tissues of the patient's body contain cancer stem cells, which have a certain tolerance to chemotherapy and radiotherapy. These cancer stem cells can exist as "roots" or circulate in the body, leading to cancer recurrence. Cancer stem cells are the main target for the development of anti-cancer drugs, but they are difficult to identify, mainly because they are often very small in number in cancer tissues. Understanding the molecular mechanism of cancer stem cells is of great significance for the development of new cancer therapies.

[0006] Although there have been a lot of studies on the application of hydrogel systems in in vitro three-dimensional cell culture, there are still some problems to be solved in these works. First, the method of recovering cells from the hydrogel culture system is complicated and time-consuming. Second, due to the poor dynamic performance of the existing hydrogel culture system, the cells on the surface and different parts of the hydrogel grow unevenly, making it difficult to form cell clone clusters. Third, the preparation and use costs are high, which is not suitable for large-scale application. Summary of the invention

[0007] One of the purposes of the present application is to provide a hydrogel with adjustable dynamic properties. The raw materials of the hydrogel are hyaluronic acid grafted with hydrophobic groups and cyclodextrin modified with cross-linking groups. After mixing in an aqueous solution, the hydrogel is formed by inducing a cross-linking reaction of the cross-linking groups. The dynamic cross-linked hydrogel quickly gels under mild conditions, has good viscoelasticity, good self-healing and shear thinning ability, and has excellent biocompatibility.

[0008] The hydrophobic group grafted onto the hyaluronic acid can act as a guest molecule to produce a host-guest interaction with the cyclodextrin as a host molecule.

[0009] In certain embodiments, the hydrophobic group is selected from butylbenzene, terpenoid or sterol molecules.

[0010] In certain embodiments, the hydrophobic group is selected from tert-butylbenzene, ibuprofen, menthol, geraniol, bile acid, and the like.

[0011] The cross-linking group of the modified cyclodextrin can be an epoxy group, an acrylate group, or a styrene double bond, etc., which can produce chemical cross-linking or photo-cross-linking. In one embodiment, the cyclodextrin is a cyclodextrin modified with a photocurable group, preferably an acrylated cyclodextrin. In some embodiments, the molecular molar ratio of acrylate groups to cyclodextrin in the acrylated cyclodextrin is 0.8-1.8. In some embodiments, the acrylated cyclodextrin is an acrylated β-cyclodextrin.

[0012] The hydrogel of the present invention is formed based on the host-guest interaction and has dynamic and adjustable performance. The host-guest recognition reaction has the characteristics of mild reaction conditions and dynamically reversible reaction process, which can not only effectively overcome the limitations of covalent binding, but also simulate biological functions at the molecular level. The host-guest interaction is based on non-covalent bond interaction. Non-covalent interactions include van der Waals forces, electrostatic attraction, hydrophobic interactions and hydrogen bonds, which are the key to the host-guest recognition effect. Different guest molecular structures have different binding constants with the host molecules, and the dynamic properties of the dynamic cross-linked hydrogel can be adjusted according to them.

[0013] The adjustment of the grafting rate of hyaluronic acid in the hydrogel of the present invention can obtain hydrogels with different dynamic properties to achieve different application scenarios, for example, according to different cultured cell systems. The calculation method of the grafting rate can be obtained by nuclear magnetic resonance detection of the ratio of the hyaluronic acid active sites connected to the grafted groups and the total active sites of the hyaluronic acid. The grafting rate of the hyaluronic acid is 5%-80%. In a preferred embodiment, the grafting rate of the hyaluronic acid can be 10%-60%. In some embodiments, the grafting rate of the hyaluronic acid can be 20%-50%; in some embodiments, the hyaluronic acid can have a grafting rate of 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70% or 80%.

[0014] The hydrogel of the present invention is degradable. After adding a guest molecule with stronger binding ability with cyclodextrin, the hydrogel can achieve rapid degradation. Preferably, adamantane hydrochloride, menthol, terpineol and its structural isomers, tert-butyl benzoate, Triton X-100, etc. can be added.

[0015] The novel hydrogel prepared by the present invention exhibits the following advantages: 1) The raw materials of the hydrogel scaffold and the host-guest molecules are safe compounds that are harmless to cells. Among them, hyaluronic acid is a medical material certified by the FDA, and the guest small molecules grafted with hyaluronic acid mostly come from natural medicines, so the prepared hydrogel has excellent biocompatibility and biochemical activity; the introduction of some functional guest molecules can bring more functions to the modified hydrogel, for example, ibuprofen hyaluronic acid hydrogel has anti-inflammatory effects; 2) Due to the use of a variety of host-guest interactions with different dynamic parameters, the new hydrogel has good adjustable dynamic mechanical properties and mechanical firmness, good long-term stability, and is suitable for long-term in vitro culture of a variety of cells; 3) The reversibility of the cross-linking point gives the hydrogel network dynamics, so that the novel hydrogel has the ability to self-repair and heal, and can be reintegrated after mechanical rupture. The dynamic network structure of the new hydrogel is conducive to promoting the formation of clusters of cells loaded inside it, which can effectively promote the proliferation and differentiation of cells; 4) In addition, the cyclodextrin main structure contained in the hydrogel has a package and sustained release effect on non-water-soluble drugs, thereby enhancing the ability of the hydrogel to regulate cell behavior; 5) Since the cross-linking mode of the hydrogel system belongs to weak interaction, after adding guest molecules with stronger binding ability, the hydrogel can be degraded and release the cell clusters loaded therein, thereby achieving the bio-friendly acquisition and recovery of cell clusters. These properties make the new hydrogel an ideal culture platform and can be applied to a variety of cell culture systems.

[0016] Another object of the present application is to provide a method for preparing a dynamically cross-linked hyaluronic acid hydrogel. The method comprises the following steps:

[0017] 1) preparing acrylated β-cyclodextrin;

[0018] 2) preparing hydrophobic group-grafted hyaluronic acid;

[0019] 3) mixing acrylated β-cyclodextrin and hydrophobic group-grafted hyaluronic acid in an aqueous solution to obtain a hydrogel prepolymer;

[0020] 4) adding a cross-linking initiator to the hydrogel prepolymer to initiate a cross-linking reaction, thereby obtaining a degradable dynamic cross-linked hydrogel.

[0021] Preferably, in the hydrogel prepolymer, the content of the hydrophobic group-grafted hyaluronic acid is 1%-10% (w / v), and the content of the acrylated β-cyclodextrin is 1%-10% (w / v).

[0022] In one embodiment, the steps of the preparation method are:

[0023] 1) Preparation steps of acrylated β-cyclodextrin:

[0024] Dissolve β-cyclodextrin in dimethylformamide (DMF), add triethylamine, and lower the system temperature to 0°C; add acryloyl chloride in an amount of 5-10 times the molar amount of cyclodextrin dropwise to the system, remove triethylamine hydrochloride by suction filtration, and obtain a clear solution, i.e., a reaction product; concentrate the reaction product by vacuum rotary evaporation, and vacuum dry to obtain acrylated β-cyclodextrin (Ac-CD);

[0025] 2) Preparation of tert-butylbenzene grafted hyaluronic acid:

[0026] The hyaluronic acid aqueous solution is adjusted to pH 7.0 with a tetrabutylammonium hydroxide aqueous solution to obtain tetrabutylammonium hydroxide salt of hyaluronic acid HA-TBA; HA-TBA is dissolved in dimethyl sulfoxide, and 2-4 times the molar amount of p-tert-butylphenylacetic acid, 0.5-1 times the molar amount of 4-dimethylaminopyridine, and 1.0-1.5 times the molar amount of di-tert-butyl dicarbonate are added in sequence, and reacted at 45° C.; freeze-dried to obtain p-tert-butylbenzene-modified hyaluronic acid HA-TP;

[0027] 3) mixing and dissolving the p-tert-butylbenzene-modified hyaluronic acid and acrylated β-cyclodextrin in PBS buffer to obtain HA-TP hydrogel prepolymer;

[0028] 4) Adding a photoinitiator to the hydrogel prepolymer, and obtaining a dynamically cross-linked hyaluronic acid hydrogel under light conditions.

[0029] Preferably, in the hydrogel prepolymer solution, the mass percentage of the hydrophobic group-modified hyaluronic acid is 1%-10% (w / v), and the mass percentage of the acrylated β-cyclodextrin is 1%-10% (w / v).

[0030] Preferably, the initiators used in the present application include: visible light initiators, such as phenyl (2,4,6-trimethylbenzoyl) phosphate lithium salt and phenyl (2,4,6-trimethylbenzoyl) phosphate sodium salt, which can perform cross-linking reaction in the blue light range (wavelength 405nm);

[0031] UV initiators, such as 2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-propanone (I2959), phenylbis(2,4,6-trimethylbenzoyl)phosphine oxide (I819), benzil dimethyl ether (I651), α-ketoglutaric acid, etc., initiate crosslinking reaction under ultraviolet light range (320nm-400nm);

[0032] Infrared photoinitiators, such as bacteriochlorophyll a, polymethines, dye-borate, alkyne cyanine dye 718, etc., initiate cross-linking reactions under infrared light.

[0033] Another object of the present application is to provide an application of culturing cells in vitro using dynamically cross-linked hyaluronic acid hydrogel.

[0034] In one embodiment, the hydrogel is used for in vitro culture of embryonic stem cells. The dynamic cross-linked hydrogel based on the host-guest system of the present invention can significantly promote the expansion and pluripotency maintenance of mouse embryonic stem cell clusters, and provide an excellent three-dimensional culture microenvironment for embryonic stem cells.

[0035] In one embodiment, the hydrogel is used to culture neural stem cells in vitro.

[0036] In another embodiment, the hydrogel is used to culture cancer cell lines in vitro, such as fibrosarcoma, myxosarcoma, liposarcoma, chondrosarcoma, osteogenic sarcoma, chordoma, angiosarcoma, endotheliosarcoma, lymphangiosarcoma, lymphangioendotheliosarcoma, synovioma, mesothelioma, Ewing's tumor, leiomyoma, rhabdomyosarcoma, colon cancer, pancreatic cancer, breast cancer, ovarian cancer, prostate cancer, squamous cell carcinoma, basal cell carcinoma, sweat gland carcinoma, sebaceous gland carcinoma, papillary carcinoma, papillary adenocarcinoma, Cystadenocarcinoma, medullary carcinoma, bronchogenic carcinoma, renal cell carcinoma, hepatocellular carcinoma, bile duct carcinoma, choriocarcinoma, seminoma, embryonal carcinoma, Wilm's tumor, cervical cancer, testicular tumor, lung cancer, small cell lung cancer, bladder cancer, epithelial cancer, glioma, astrocytoma, medulloblastoma, craniopharyngioma, ependymoma, pinealoma, hemangioblastoma, acoustic neuroma, oligodendroglioma, meningioma, melanoma, neuroblastoma, and retinoblastoma. Preferably, the cancer cell line is selected from cervical cancer cell line, human neuroblastoma cell line and B16 melanoma cell line.

[0037] Another object of the present application is to provide a method for culturing cells in vitro using the dynamically cross-linked hyaluronic acid hydrogel. The method comprises the following steps:

[0038] a) mixing and dissolving hydrophobic group-modified hyaluronic acid and acrylated β-cyclodextrin in PBS buffer to obtain a hydrogel prepolymer;

[0039] b) adding a photoinitiator to the hydrogel prepolymer, mixing the cells, and obtaining a hydrogel encapsulating the cells under light conditions, adding a culture solution, and culturing the hydrogel in a culture box;

[0040] c) adding a guest small molecule compound with stronger binding ability with cyclodextrin to the hydrogel encapsulating the cells, degrading the hydrogel, and collecting the cultured cell clusters. Preferably, amantadine hydrochloride, menthol, terpineol and its structural isomers, tert-butyl benzoate, Triton X-100, etc. can be added.

[0041] The present application also provides a method for reprogramming cancer cells in vitro to differentiate them into cancer stem cells. The method comprises using the dynamically cross-linked hyaluronic acid hydrogel to load cancer cell lines, and performing cell culture, and recovering cell clusters after the hydrogel is degraded. Preferably, the dynamically cross-linked hyaluronic acid hydrogel is formed by tert-butylbenzene-grafted hyaluronic acid and cyclodextrin modified with a photocurable group under photoinitiator conditions.

[0042] In one embodiment, by using the hydrogel of the present invention to culture cancer cells, the cancer cells loaded in the hydrogel will form obvious cluster structures and produce special molecular markers of cancer stem cells such as SOX2, Oct3 / 4 and NANOG, indicating that these cancer cells have been reprogrammed. The released cell clusters were tested for drug resistance, and the results showed that the clusters had obvious drug tolerance to the anticancer drug Dox, further indicating that the cancer cells have achieved the transformation into cancer stem cells.

[0043] The present invention further provides a method for rapidly recovering cells from the hydrogel three-dimensional cell culture system. The hydrogel system of the present invention achieves rapid degradation by this method. The method includes adding a guest small molecule compound with stronger binding ability with cyclodextrin to the hydrophobic group-grafted hyaluronic acid dynamic cross-linked hydrogel system to achieve good degradation performance, and can achieve complete degradation of the hydrogel within 15 minutes, and release the encapsulated cell clusters. Experiments have shown that the released cell clusters have good activity. The guest small molecule is preferably an aqueous solution of adamantane hydrochloride with a concentration of 20-80mM, and the hydrogel degradation time is 5-15 minutes.

[0044] In addition, since hyaluronic acid will naturally degrade under the action of hyaluronidase in the body, when the dynamic cross-linked hyaluronic acid hydrogel is injected or filled in the body, no other reagents are needed, and the loaded cells or drugs can be gradually released. The dynamic cross-linked hyaluronic acid hydrogel of the present application can also be used to deliver drugs into the body.

[0045] Another object of the present application is to provide a composite dynamic cross-linked hydrogel, the preparation method of which is to mix a hydrogel of hyaluronic acid grafted with a hydrophobic group and a cyclodextrin modified with a cross-linking group, add gelatin to obtain a hydrogel prepolymer, add a chemical cross-linking initiator or a photoinitiator and form a hydrogel under light conditions. The molar ratio of hyaluronic acid grafted with a hydrophobic group to gelatin in the hydrogel is 3:1-1:6, preferably, the molar ratio of hyaluronic acid grafted with a hydrophobic group to gelatin in the hydrogel is 1:1-1:4.

[0046] The present application further provides the use of the composite dynamic cross-linked hydrogel in three-dimensional cultured cells.

[0047] Another object of the present application is to provide the application of the dynamically cross-linked hyaluronic acid hydrogel in the preparation of a therapeutic agent, wherein the dynamically cross-linked hyaluronic acid hydrogel is loaded with cells and / or drugs and delivered into the body, and the cells are embryonic stem cells, neural stem cells or immune cells. Since the dynamically cross-linked hyaluronic acid hydrogel is gradually degraded in the body due to the action of hyaluronidase, the application can achieve safe, efficient and long-term delivery of therapeutic cells and / or drugs into the body.

[0048] Another object of the present application is to provide an injectable dynamic cross-linked hydrogel. By introducing gelatin dynamic cross-linked hydrogel into the dynamic cross-linked hyaluronic acid hydrogel, the obtained composite dynamic cross-linked hydrogel has injectable properties. Preferably, the composite dynamic cross-linked hydrogel is loaded with three-dimensional cultured cells, and preferably the composite dynamic cross-linked hydrogel is loaded with cells and / or therapeutic drugs. Enzymes in the body, such as collagenase, can degrade the dynamic composite cross-linked hydrogel, thereby gradually releasing the cells or drugs loaded thereon, and achieving effects such as continuous treatment of the lesion site. For example, after the resection of the tumor site, there are often residual tumor cells that may cause the hidden danger of recurrence. The hydrogel loaded with immune cells and / or anti-tumor drugs is injected into the tumor resection site, which can not only play a filling role, but also play a role in continuously inhibiting tumor cell proliferation and reducing recurrence. Further, the present application provides the use of the composite dynamic cross-linked hydrogel in the preparation of therapeutic agents, wherein the composite dynamic cross-linked hydrogel loads cells and / or drugs and delivers them to the body, and the cells are embryonic stem cells, neural stem cells or immune cells.

[0049] The dynamic hydrogel developed by the present invention has good dynamic performance and can realize the three-dimensional culture of various cells, including but not limited to embryonic stem cells, neural stem cells, immune cells and cancer cell lines. The obtained cell clusters remain highly active and can be recycled and studied by cell-friendly degradation. These characteristics are of great significance for disease treatment and basic research.

[0050] The hydrogel of the invention of this patent can provide the required dynamic microenvironment for cell types that grow in clusters, such as embryonic stem cells and cancer stem cells. The results of the study show that the self-assembled dynamic cross-linked gel of the present application can not only promote the proliferation and stemness of embryonic stem cells in long-term three-dimensional culture, but also reprogram cancer cells of various different types of cancer cell lines to differentiate them into cancer stem cells within a few days. When the above-mentioned types of cancer cells are loaded in a dynamic hydrogel gel for three-dimensional culture, they will begin to form a cluster structure and produce special molecular markers of cancer stem cells, such as SOX2 and Oct3 / 4, thereby indicating that the cancer cells have been reprogrammed. The present invention is a valuable culture system that can support long-term three-dimensional culture of embryonic stem cells, and is of great value to the mechanism research of cancer development and metastasis and the basic research of anticancer drugs. The beneficial effect of the present invention is that the degradable dynamic hydrogel provided by the present invention for promoting 3D culture of cell clusters is lower in cost than traditional extracellular matrix hydrogels (such as Matrigel). It can be widely used in the study of various in vitro cell clusters, and is expected to promote the research of embryonic stem cells and the development and precision treatment of new anticancer drugs. BRIEF DESCRIPTION OF THE DRAWINGS

[0051] Figure 1 Storage modulus G' and elastic modulus G" of dynamically cross-linked hyaluronic acid hydrogels: (A) tert-butylphenyl hyaluronic acid; (B) ibuprofen hyaluronic acid; (C) menthol hyaluronic acid; (D) geraniol hyaluronic acid; (E) bile acid hyaluronic acid.

[0052] Figure 2 Schematic diagram of the distribution of internal cell clusters formed when B16 cell line was cultured in HA-TP hydrogel and Matrigel, respectively.

[0053] Figure 3 Schematic diagram of the distribution of internal cell clusters formed when SH-SY5Y cell line was cultured in HA-TP hydrogel and Matrigel, respectively.

[0054] Figure 4 Schematic diagram of the distribution of internal cell clusters formed when HeLa cell lines were cultured in HA-TP hydrogel and Matrigel, respectively.

[0055] Figure 5 Immunofluorescence detection of HeLa cell clusters in HA-TP hydrogels with different contents (2%, 3% and 4%).

[0056] Figure 6 Immunofluorescence detection of three cell lines (HeLa, B16 and SH-SY5Y) loaded in HA-TP hydrogels after 7 days of culture.

[0057] Figure 7Immunofluorescence detection of HeLa cell clusters cultured in hydrogels 36 hours after administration of 0.5 nM doxorubicin.

[0058] Figure 8 T cells appeared in cell clusters after 7 days of culture in HA-TP hydrogels.

[0059] Fig. 9 Expression of TNFα and IFNγ by T cells cultured in HA-TP hydrogels.

[0060] Fig.10 Fluorescence staining experimental results of ZAP70 and LCK in T cells cultured in HA-TP hydrogel.

[0061] Fig.11 Experiment on injectable properties of composite dynamically cross-linked hydrogel.

[0062] Fig.12 Immunofluorescence experiment and bright field microscopy observation results of 3T3 cells in composite dynamic cross-linked hydrogels. Actin represents the fluorescent labeling of actin, and Nucleus represents the fluorescent labeling of 3T3 cell nuclei.

[0063] Fig.13 LCK immunofluorescence staining experiment after immune T cells were cultured in the composite dynamic hydrogel for 7 days. DAPI represents the cell nucleus fluorescent staining marker.

[0064] Fig.14 ZAP 70 immunofluorescence staining experiment after immune T cells were cultured in the composite dynamic hydrogel for 7 days. DAPI represents the cell nucleus fluorescent staining marker.

[0065] Figure 15 NMR spectra of hyaluronic acid grafted with different hydrophobic molecules. DETAILED DESCRIPTION

[0066] Instruments and reagents

[0067] Rotational rheometer (Anton Paar MCR01)

[0068] Laser confocal microscope (Nikon ECLIPSE TE2000-U )

[0069] Optical microscope (Nikon DS-Fi2)

[0070] Fluorescence microscope (LECIA THUNDER IMAGER LIVE CELL SYSTEM)

[0071] Cervical cancer cell line (HeLa) was purchased from American Type Culture Collection (ATCC) CCL-2; human neuroblastoma cell line (SH-SY5Y) was purchased from American Type Culture Collection (ATCC) CRL-2266; B16 melanoma cell line (B16-F0) was purchased from American Type Culture Collection (ATCC) CRL-6322. Immune CD8+T cells and 3T3 cells were from Shanghai Cell Bank, Chinese Academy of Sciences.

[0072] Other reagents were commercially available.

[0073] Example 1 Preparation of HA-TP hydrogel

[0074] 1) Preparation steps of acrylated β-cyclodextrin:

[0075] β-cyclodextrin was dissolved in dimethylformamide (DMF) to obtain a 6% (w / v) β-cyclodextrin / DMF solution, triethylamine was added at a ratio of 4.5% (v / v), and the system temperature was lowered to 0°C; acryloyl chloride in an amount of 7 times the molar amount of cyclodextrin was added dropwise to the system, and stirring was continued for 12 hours after the addition was completed, and triethylamine hydrochloride was removed by suction to obtain a clear solution, i.e., a reaction product;

[0076] The reaction product was concentrated by vacuum rotary evaporation, and the concentrated solution of the reaction product was added dropwise to 10 times the volume of acetone to obtain a white precipitate, and the obtained white precipitate was washed with acetone, and finally vacuum dried to obtain acrylated β-cyclodextrin (Ac-CD).

[0077] 2) Preparation steps of p-tert-butylbenzene grafted hyaluronic acid:

[0078] Sodium hyaluronate (molecular weight: 80,000) was prepared into a 1% aqueous solution, to which 6 times the mass of sodium hyaluronate cation exchange resin was added, and stirred at room temperature for 8 hours;

[0079] The resin was removed by suction filtration to obtain a post-reaction solution. The pH of the obtained solution was adjusted to 7.0 with an aqueous solution of tetrabutylammonium hydroxide, and freeze-dried to obtain tetrabutylammonium hydroxide salt of hyaluronic acid HA-TBA;

[0080] Dissolve HA-TBA in dimethyl sulfoxide to prepare a 1% HA-TBA dimethyl sulfoxide solution. Take the molar number of the HA-TBA structural unit as 1 equivalent, add 3 equivalents of p-tert-butylphenylacetic acid, 0.75 equivalents of 4-dimethylaminopyridine, and 1.2 equivalents of di-tert-butyl dicarbonate to the above solution system in sequence, and react at 45°C for 24 hours;

[0081] The reaction mixture was dialyzed against DMSO for 3 days, against saturated saline for 1 day, and against pure water for 3 days, and then freeze-dried to obtain p-tert-butylbenzene-modified hyaluronic acid HA-TP.

[0082] 3) Preparation steps of p-tert-butylbenzene grafted hyaluronic acid-cyclodextrin hydrogel prepolymer:

[0083] The p-tert-butylbenzene grafted hyaluronic acid and acrylated β-cyclodextrin (Ac-CD) are mixed and dissolved in PBS buffer to obtain HA-TP hydrogel prepolymer. The hydrogel prepolymer solution consists of a mixed solution of p-tert-butylbenzene grafted hyaluronic acid (HA-TP) and acrylated β-cyclodextrin (Ac-CD), wherein the solid content of HA-TP is 4% (w / v) and the solid content of Ac-CD is 3% (w / v).

[0084] 4) Adding I 2959 photoinitiator to the hydrogel prepolymer solution, mixing with cells, and obtaining a degradable dynamic hydrogel encapsulating cells under ultraviolet light initiation conditions, adding culture fluid, and culturing in an incubator. After 7 days of culturing, adding an aqueous solution of amantadine hydrochloride to the cell-loaded hydrogel prepolymer solution to degrade the hydrogel, and collecting the cultured cell clusters.

[0085] Example 2 Preparation of different types of dynamically cross-linked hyaluronic acid hydrogels

[0086] According to the method similar to the preparation steps of tert-butylbenzene grafted hyaluronic acid, hyaluronic acid grafted with different hydrophobic molecules was prepared respectively. The method is to dissolve HA-TBA in dimethyl sulfoxide to prepare a 1% HA-TBA dimethyl sulfoxide solution. Taking the molar number of HA-TBA structural unit as 1 equivalent, 3 equivalents of corresponding types of hydrophobic molecules (isobufenpropionic acid, menthol succinate monoester, geraniol succinate monoester, bile acid), 0.75 equivalents of 4-dimethylaminopyridine, 1.2 equivalents of di-tert-butyl dicarbonate were added to the above solution system in sequence, and reacted at 45°C for 24 hours; the reaction mixture was dialyzed against DMSO for 3 days, dialyzed against saturated saline for 1 day, dialyzed against pure water for 3 days, and freeze-dried to obtain the target product. Among them, the preparation methods of hyaluronic acid grafted with different guest molecules are shown in Table 1.

[0087] According to the method in Example 1, dynamic cross-linked hyaluronic acid hydrogels formed by assembling different host-guest molecules were prepared using hyaluronic acid grafted with different guest molecules. The nuclear magnetic resonance spectra of hyaluronic acid grafted with different hydrophobic molecules are shown in FIG15 .

[0088] Table 1 Preparation of hyaluronic acid grafted with different guest molecules

[0089]

[0090]

[0091] Example 3 Dynamic Mechanical Properties of Dynamically Cross-linked Hyaluronic Acid Hydrogels

[0092] The dynamic cross-linked hyaluronic acid hydrogel network of the present invention has good cell adaptability and mechanical dynamics. The various hydrogels prepared in Example 2 and commercially available extracellular matrix hydrogel Matrigel hydrogel were respectively tested for storage modulus and loss modulus of the hydrogel using a rotational rheometer. By comparing the results, it was found that the hydrogel prepared by the present invention has better dynamic mechanical properties, and its loss modulus is as shown in Table 2, which is greater than the extracellular matrix hydrogel with the same hardness.

[0093] In addition, the hydrogels of the present invention exhibit strong frequency dependence (see Figure 1 ), as the frequency of the applied shear force gradually decreases, the storage modulus and loss modulus of the hydrogel decrease simultaneously, which indicates that the hydrogel has good dynamic properties.

[0094] The storage modulus, also known as the elastic modulus, refers to the amount of energy stored in the material due to elastic (reversible) deformation when the material is deformed, reflecting the elasticity of the material; the loss modulus, also known as the viscous modulus, refers to the amount of energy lost due to viscous deformation (irreversible) when the material is deformed, reflecting the viscosity of the material.

[0095] Table 2 Dynamic mechanical properties of hydrogels

[0096]

[0097] In this study, hyaluronic acid macromolecules were modified with guests with different binding abilities to β-cyclodextrin to obtain macromolecular guests. Acrylic acid-modified cyclodextrin was used to pre-assemble with the macromolecular guests, and then a dynamic cross-linked hydrogel was obtained by photoinitiation. Figure 1 It can be seen that the hydrogels formed by guest macromolecules with different binding abilities have different rheological characteristics. Guest molecules with relatively strong binding abilities, such as tert-butylbenzene and bile acid, have faster gelation time and relatively higher storage modulus, while guest molecules with relatively weaker binding abilities have slower gelation time and relatively weaker storage modulus.

[0098] Example 4 HA-TP hydrogel is used for the culture of melanoma cells of mouse tumor cell line

[0099] Mouse tumor cell line melanoma (B16) was 4×10 6 The cells / mL density was mixed with the hydrogel prepolymer solution and initiated by ultraviolet light to obtain the cell-loaded hydrogel. Conventional cell culture medium (basal medium) was added to 500 μl of the hydrogel and cultured statically in an incubator.

[0100] After 7 days of culture, an aqueous solution of amantadine hydrochloride was added to the cell-loaded hydrogel to degrade the hydrogel and collect the cultured cell clusters. The concentration of the aqueous solution of amantadine hydrochloride was 50 mM and the hydrogel degradation time was 5-15 minutes.

[0101] Mouse tumor cell line melanoma (B16) was seeded at the same density (4×10 6 cells / mL) were mixed with Matrigel prepolymer solution to form hydrogel as a control. The results of the clone size of the cells cultured in the two groups of hydrogels observed under an optical microscope are shown in Figure 2 The results showed that during the 7-day culture process, as the culture time increased, B16 cell clones gradually formed in the HA-TP hydrogel, with the size increasing from 700 μm to 1.5 μm. 2 Gradually increase to 12500μm 2 , and the size of cell clones inside and outside the hydrogel is uniform. Compared with HA-TP, the cell clones in the outer layer of the edge of Matrigel hydrogel grow significantly, while the cells in the middle and inner layers are spread out and cannot form obvious cell clones, and the overall cell clone distribution is uneven.

[0102] After 7 days of culture, the HA-TP hydrogel encapsulating cancer cells is degraded by adding an ADA (amantadine hydrochloride) aqueous solution to achieve cell cluster recovery, and the recovered cell clusters can be degraded by trypsin to obtain single cells; in contrast, after 7 days of culture, the Matrigel hydrogel encapsulating cancer cells can only be degraded by adding trypsin, and the addition of trypsin will also digest the cell clusters, and the cell clusters cannot be completely recovered and only single cells can be obtained. As a preferred technical solution of the present invention, the concentration of the amantadine hydrochloride aqueous solution is 50mM, and the hydrogel degradation time is 5-15 minutes.

[0103] Example 5 Human neuroblastoma cell line culture

[0104] Using the experimental method of Example 4, human neuroblastoma cell line (SH-SY5Y) was seeded in HA-TP hydrogel and Matrigel, respectively, and cultured in conventional cell culture medium, such as RPMI1640, DMEM medium, etc. The results showed that during the 7-day culture process, as the culture time increased, SH-SY5Y cell clones gradually formed, with a size ranging from 2000 μm to 400 μm. 2 Gradually increase to 25000μm 2 Compared with HA-TP, the cell clones in the outer layer of the Matrigel hydrogel edge grew significantly, while the cells in the middle and inner layers were spread out and could not form obvious cell clones. The overall cell clone distribution was uneven. Figure 3 shown.

[0105] Example 6 Hela cell cluster culture

[0106] Using the experimental method of Example 4, human cervical cancer cell line (Hela) was implanted in HA-TP hydrogel and Matrigel for culture. Immunofluorescence staining was used to detect the expression of NANOG and Oct 3 / 4 in the cells on days 2, 4, and 7 (see Figure 4 , Figure 5 ).

[0107] By observing the cell clone size of Hela cells cultured in HA-TP hydrogel and Matrigel, cluster structures were formed at the edge, middle and center of HA-TP hydrogel, while cells inside Matrigel could not form clusters. Figure 4 As shown; through the analysis of the size distribution of cell clusters formed at different positions of the two hydrogels, it can be seen that the size of the cell clusters formed from the inside to the outside in the HA-TP hydrogel is uniform, the size of the cell clusters formed in Matrigel is uneven, and the hydrogel cell clusters inside Matrigel are not easy to form.

[0108] The expression of homeobox protein (NANOG) and octamer-binding transcription factor 4 (Oct 3 / 4) is essential for the self-renewal and maintenance of stem cell stemness. Hela cells were loaded in HA-TP hydrogels and cultured for 7 days. The results of immunofluorescence staining showed that the cell clones in HA-TP hydrogels with different solid contents showed a large amount of NANOG and Oct 3 / 4 expression, proving that the cell clones generated under the dynamic induction of HA-TP hydrogels have good stem cell performance and self-renewal ability. HeLa cell clusters in HA-TP hydrogels with different contents (2%, 3% and 4%, w / v) continued to grow over time, indicating that the cells have good proliferation ability in the hydrogel; cell clusters in HA-TP hydrogels expressed Oct 3 / 4 and NANOG, indicating that the cancer cells in the cell clusters were reprogrammed into cancer stem cells (see Figure 5 ).

[0109] Example 7 HA-TP hydrogel induces migration ability of cell clones

[0110] After three cell lines (HeLa, B16 and SH-SY5Y) were loaded in HA-TP hydrogel and cultured for 7 days, immunofluorescence detection results showed that HA-TP hydrogel induced the formation of cell clones expressing a large amount of Cdc 42 (see Figure 6). Cell division control protein 42 (Cdc 42) is a protein involved in cell cycle regulation and plays an important role in regulating various physiological processes such as cytoskeletal changes, polarity establishment, movement and migration. Hypoxia-inducible factor 1-α (HIF-1α) is a subunit of the heterodimeric transcription factor hypoxia-inducible factor 1 encoded by the HIF1A gene. It is considered to be the main transcriptional regulator of cellular and developmental responses to hypoxia. After three cell lines (HeLa, B16 and SH-SY5Y) were loaded in HA-TP hydrogels and cultured for 7 days, the results showed that HA-TP hydrogels induced the formation of cell clones expressing a large amount of HIF-1α (see Figure 6 The above results show that the three cell lines (HeLa, B16 and SH-SY5Y) loaded in HA-TP hydrogel for 7 days all showed high expression of Cdc42 and HIF-1α, indicating that the cells in the cell clusters were in a hypoxic environment and had good migration ability.

[0111] Example 8 Cell clone drug resistance

[0112] Human cervical cancer cell line (Hela) was loaded in HA-TP hydrogel and Matrigel and cultured for 7 days. The two groups of hydrogel samples were treated with 0.5nM doxrubicin for 36 hours, and the cell activity was observed using a fluorescence microscope after staining. The results showed (see Figure 7 ) The cell clones induced by the dynamic properties of HA-TP still maintain good cell activity. However, the Hela cells in the middle of Matrigel cannot form cell clones and die in large numbers under the action of drugs. In contrast, the Hela cells at the edge of Matrigel can form clones and still maintain good cell activity after drug treatment. The experimental results show that the Hela cell clones formed under the dynamic properties of HA-TP hydrogel have good resistance to anticancer drugs as a whole.

[0113] Example 9 HA-PT three-dimensional culture of immune cells

[0114] CD8 + T cells were obtained from splenocytes of adult mouse spleens and sorted by MojoSort according to the manufacturer's instructions (biolegend). TM The mouse CD8+T cell separation kit was used for separation. The CD8+T cells were collected by centrifuge and loaded into the HA-TP dynamic cross-linked hydrogel according to the method of Example 4.

[0115] Add 500 μl of hydrogel prepolymer mixed with CD8+ T cells (cell concentration is 1-2×10 6 / ml), after adding the photoinitiator, irradiate with 365nm ultraviolet light for 10 minutes, and add RPMI1640 culture medium supplemented with 5ug / ml mouse CD3, 5ug / ml mouse CD28, L-glutamine, 1% penicillin-streptomycin, 10% FBS and 50ng / mL IL-2.

[0116] The 24-well plate was placed in a 37°C, 5% CO 2 On day 3 of culture, the cell-loaded hydrogels were supplemented with half the volume of fresh culture medium containing 100 ng / mL IL-2 to support T cell expansion.

[0117] At the same time, the 2D method was used to culture CD8+T cells in vitro as a control, and the method was as follows:

[0118] 1) Dilute mouse CD3 antibody to 5 μg / ml with sterile PBS, add the diluted antibody to a 24-well plate, 400 μl per well, and coat overnight at 4°C;

[0119] 2) The culture medium used was: RPMI1640 + 10% serum + 5ug / ml mouse CD28 + dual antibody, and the CD8+ T cell concentration was adjusted to 1×10 6 / ml;

[0120] Take the coated plate, discard the coating solution, wash with sterile PBS three times; add 500 μl of cell suspension to each well and place in a 37°C incubator containing 5% CO 2 Culture in a cell culture incubator.

[0121] The growth morphology of cells was observed using an electron microscope every day. About 10% of the T cells showed clustering in the HA-TP hydrogel after 7 days of culture (see Figure 8 ).

[0122] The cells loaded in the HA-TP hydrogel were degraded by adding adamantane hydrochloride aqueous solution, and the cultured T cells were recovered. Immunofluorescence staining experiments were performed on T cells, and the results showed that the cultured T cells could be activated while proliferating in the HA-PT hydrogel, and the expression of TNFα and IFNγ was significantly improved compared with 2D culture ( Fig. 9 ). The cultured cells were taken for immunofluorescence staining experiments. By detecting the expression of activation indicators ZAP70 and LCK (sigma) in T cells, it was proved that the three-dimensional cultured immune cells have immune activity. The indicators ZAP70 and LCK after T cell activation have high expression (see Fig.10 ).

[0123] Example 10 Composite dynamic cross-linked hydrogel

[0124] The present invention prepares a novel composite hydrogel by mixing gelatin with other dynamic cross-linked gels based on the host-guest interaction of cyclodextrin. The obtained composite hydrogel also has injectable properties. This embodiment uses ibuprofen hyaluronic acid with anti-inflammatory effects. The preparation method is to mix a certain proportion of ibuprofen hyaluronic acid and β-cyclodextrin modified with a cross-linking group, add a gelatin solution to form a prepolymer, add a cross-linking agent initiator, and initiate cross-linking to obtain a gelatin-ibuprofen hyaluronic acid composite hydrogel. It has been experimentally verified that the composite dynamic cross-linked hydrogel has good injectability (see Fig.11 ).

[0125] Under physiological conditions (37°C), there are two different interactions inside the hydrogel: host-guest interactions between cyclodextrin and the aromatic groups in gelatin and the butylbenzene structure in ibuprofen; and electrostatic interactions between the amino groups in gelatin and the carboxyl groups of hyaluronic acid. Through experiments, it was found that at physiological temperature and room temperature, the injectable gelatin-ibuprofen hyaluronic acid composite hydrogel has a stable storage modulus, proving the stability of the hydrogel. Because the hydrogel has good adhesion-promoting properties and dynamic mechanical properties, cells encapsulated in the hydrogel can achieve rapid spreading.

[0126] 3T3 cells were used to analyze the ratio of gelatin / ibuprofen hyaluronic acid composite dynamic cross-linked hydrogel. 4% ibuprofen hyaluronic acid (HA-IBF) and 3% acrylated cyclodextrin (Ac-CD) were mixed to prepare precursor 1 (P1), and 8% gelatin was prepared as precursor 2 (P2). P1 and P2 were mixed according to the proportions in Table 3, and 3T3 cells and photoinitiators were added. The following table lists the solid content of each component in the composite hydrogel. 3T3 cells loaded on the composite hydrogel were cultured in culture medium, and immunofluorescence staining was performed one day later. The results are as follows: Fig.12 shown.

[0127] Table 3 Ratio of composite dynamic cross-linked hydrogel

[0128]

[0129] According to the above 3T3 cell culture experiment, within one day, when the solid content of HA-IBF in the hydrogel was in the range of 0.7-1.1%, the solid content of gelatin was in the range of 5.6-6.5%, and the solid content of Ac-CD was in the range of 0.55-0.8%, the immunofluorescence staining experiment showed that 3T3 cells could achieve rapid spreading (see Fig.12 ).

[0130] Furthermore, the experiment used composite dynamic cross-linked hydrogels to load hMSC cells and culture them in three dimensions. According to the ratio of P1 and P2 = 1:2.4, the composite dynamic cross-linked hydrogel was prepared, in which HA-IBF was 1%, Ac-β-CD was 0.75%, and gelatin was 4.8%, and an injectable composite dynamic cross-linked hydrogel was obtained. The structure of the hydrogel was experimentally verified to be conducive to the clonal growth and self-renewal of ESC cells.

[0131] Example 11 Three-dimensional culture of immune cells in composite dynamic cross-linked hydrogel

[0132] According to the method of Example 10, 4% of tert-butylbenzene grafted hyaluronic acid (HA-PT) and 3% of acrylated cyclodextrin (Ac-CD) were mixed to prepare precursor 1 (P1), 8% of gelatin was prepared as precursor 2 (P2), P1 and P2 were mixed in a ratio of 1:3, and immune cells CD8+T cells and photoinitiators were added to obtain a dynamic cross-linked hydrogel loaded with immune cells under the action of blue light 405nm. At the same time, tert-butylbenzene grafted hyaluronic acid-gelatin dynamic cross-linked hydrogel (PT-Gel) and ibuprofen grafted hyaluronic acid-gelatin dynamic cross-linked hydrogel (BU-Gel) were used to routinely culture CD8+T cells according to the method of Example 9. On the seventh day, the cultured cells were subjected to immunofluorescence staining to detect the expression of ZAP 70 and LCK proteins. Fig.13 and Fig.14 As shown, the immune T cells cultured three-dimensionally in the dynamic composite cross-linked hydrogel differentiated and proliferated well on the 7th day, forming cell clusters and maintaining immune activity. The immune cells cultured by the dynamic cross-linked hydrogel can be directly used for in vivo injection, wherein the loaded immune cells can be gradually degraded under the action of collagenase in vivo, and the released immune cells have strong immune activity and can play a good therapeutic role.

Claims

1. A dynamically cross-linked hyaluronic acid hydrogel, characterized in that: The hydrogel is a hydrogel prepolymer mixed with hyaluronic acid grafted with a hydrophobic group and cyclodextrin modified with a cross-linking group, and the hydrogel is formed by inducing a cross-linking reaction of the cross-linking group; Wherein, the hydrophobic groups grafted onto the hyaluronic acid are selected from tert-butylbenzene, ibuprofen, and menthol groups.

2. The hydrogel according to claim 1, characterized in that The cross-linking group of the modified cyclodextrin is selected from an epoxy group, an acrylate group, or a styrene double bond group.

3. The hydrogel according to claim 2, characterized in that The cross-linking groups of the cyclodextrin are acrylate groups.

4. The hydrogel according to claim 1, characterized in that The grafting rate of the hyaluronic acid is 5%-80%.

5. The hydrogel according to claim 1, characterized in that The grafting rate of the hyaluronic acid is 10%-60%.

6. A method for preparing the dynamically cross-linked hyaluronic acid hydrogel according to claim 1, comprising the following steps: 1) preparing cyclodextrin modified with cross-linking groups; 2) preparing hyaluronic acid grafted with hydrophobic groups; 3) mixing the cross-linking group-modified cyclodextrin and the hydrophobic group-grafted hyaluronic acid in an aqueous solution to obtain a hydrogel prepolymer; 4) adding a chemical crosslinking agent or a photoinitiator to the hydrogel prepolymer and initiating a crosslinking reaction under light conditions to obtain a dynamically crosslinked hydrogel; Characterized in that the hydrophobic group is selected from tert-butylbenzene, ibuprofen and menthol.

7. The method according to claim 6, characterized in that The following steps are involved: 1) Preparation steps of acrylated β-cyclodextrin: Dissolve β-cyclodextrin in dimethylformamide, add triethylamine, and lower the system temperature to 0°C; add acryloyl chloride in an amount of 5-10 times the molar amount of cyclodextrin dropwise to the system, remove triethylamine hydrochloride by suction filtration, and obtain a clear solution, i.e., a reaction product; concentrate the reaction product by vacuum rotary evaporation, and vacuum dry to obtain acrylic acid esterified β-cyclodextrin; 2) Preparation of p-tert-butylbenzene grafted hyaluronic acid: The hyaluronic acid aqueous solution is adjusted to pH 7.0 with a tetrabutylammonium hydroxide aqueous solution to obtain tetrabutylammonium hydroxide salt of hyaluronic acid HA-TBA; HA-TBA is dissolved in dimethyl sulfoxide, and 2-4 times the molar amount of p-tert-butylphenylacetic acid, 0.5-1 times the molar amount of 4-dimethylaminopyridine, and 1.0-1.5 times the molar amount of di-tert-butyl dicarbonate are added in sequence, and reacted at 45° C.; freeze-drying is performed to obtain p-tert-butylbenzene-grafted hyaluronic acid HA-TP; 3) dissolving p-tert-butylbenzene grafted hyaluronic acid and acrylated β-cyclodextrin in PBS buffer to obtain HA-TP hydrogel prepolymer; in the hydrogel prepolymer, the w / v content of the hyaluronic acid grafted with the hydrophobic group is 1%-10%, and the w / v content of the acrylated β-cyclodextrin is 1%-10%; 4) adding a photoinitiator to the hydrogel prepolymer solution, and obtaining a dynamically cross-linked hyaluronic acid hydrogel under light conditions.

8. Use of the dynamically cross-linked hyaluronic acid hydrogel according to any one of claims 1 to 5 in culturing cells in vitro.

9. The use according to claim 8, characterized in that: The cells are embryonic stem cells, neural stem cells, immune cells or cancer cell lines.

10. A method for culturing cells in vitro using the dynamically cross-linked hyaluronic acid hydrogel according to any one of claims 1 to 5, comprising the following steps: a) mixing the hydrophobic group-grafted hyaluronic acid and acrylated β-cyclodextrin and dissolving them in PBS buffer to obtain a hydrogel prepolymer; in the hydrogel prepolymer solution, the w / v content of the hydrophobic group-grafted hyaluronic acid is 1%-10%, and the w / v content of the acrylated β-cyclodextrin is 1%-10%; b) adding a photoinitiator to the hydrogel prepolymer solution, mixing in cells, and obtaining a cell-loaded hydrogel under light conditions; adding the cell-loaded hydrogel to a culture solution, and culturing the solution in a culture box; c) adding a small molecule that reacts with cyclodextrin to produce a stronger host-guest interaction with the hyaluronic acid grafted with the hydrophobic group to the cell-loaded hydrogel, degrading the hydrogel, and collecting the cultured cell clusters.

11. The method according to claim 10, characterized in that The small molecule is selected from adamantane hydrochloride, menthol, terpineol and its structural isomers, tert-butyl benzoate, and Triton X-100.

12. Use of the dynamically cross-linked hyaluronic acid hydrogel according to any one of claims 1 to 5 in the preparation of a therapeutic agent, wherein the dynamically cross-linked hyaluronic acid hydrogel is loaded with cells and / or drugs and delivered into the body, and the cells are embryonic stem cells, neural stem cells or immune cells.

13. A method for reprogramming cancer cells in vitro to differentiate them into cancer stem cells, comprising loading cancer cell lines with the dynamically cross-linked hyaluronic acid hydrogel according to any one of claims 1 to 5, and culturing the cells in a cell culture medium.

14. A composite dynamic cross-linked hydrogel, comprising the dynamic cross-linked hyaluronic acid hydrogel and the dynamic cross-linked gelatin hydrogel according to any one of claims 1 to 5; the preparation method thereof is to mix the hyaluronic acid grafted with a hydrophobic group and the cyclodextrin modified with a cross-linking group in an aqueous solution, add gelatin, and then add a chemical cross-linking initiator or a photoinitiator to form a hydrogel under light conditions.

15. The composite dynamically cross-linked hydrogel according to claim 14, characterized in that: The molar ratio of the hyaluronic acid grafted with the hydrophobic group to the gelatin in the hydrogel is 3:1-1:

6.

16. Use of the composite dynamic cross-linked hydrogel according to any one of claims 14 to 15 in three-dimensional cultured cells.

17. Use of the composite dynamic cross-linked hydrogel according to any one of claims 14 to 15 in preparing an injectable hydrogel, wherein the composite dynamic cross-linked hydrogel is loaded with cells and / or other drugs.

18. The use according to claim 17, characterized in that The cells are embryonic stem cells, neural stem cells or immune cells.

19. Use of the composite dynamic cross-linked hydrogel according to any one of claims 14 to 15 in the preparation of a therapeutic agent, wherein the composite dynamic cross-linked hydrogel loads cells and / or drugs and delivers them into the body, and the cells are embryonic stem cells, neural stem cells or immune cells.